Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 17, 2013Transfusion

A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia

View Full Paper
Ask AI
Bookmark
Share

Authors

JOJane E. OnkenDBDavid B. BregmanRHRobert A. Harrington

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Onken et al. (2013) studied this question.

synapsesocial.com/papers/6a72a4d46c240de38cdc6da4https://doi.org/10.1111/trf.12289
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease2010 · 441 citations
  2. 2Hepcidin and iron regulation, 10 years later2011 · 962 citations
  3. 3Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia2008 · 176 citations
  4. 4Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency2009 · 2,090 citations
  5. 5Iron Deficiency Anemia2008 · 378 citations